Hemolytic-uremic syndrome (HUS), which is characterized by acute renal insufficiency, microangiopathic hemolytic anemia, and thrombocytopenia (5, (7) (8) (9) (10) , constitutes an important clinical problem in pediatric populations in Chile, Argentina, and Uruguay (4, 5, 9, 22, 36) . In Argentina and Chile, HUS is the most common cause of acute renal insufficiency in children less than 4 years of age, and a proportion of affected children die of this illness (4, 5, 9, 22, 36) . As experience accumulated worldwide, it became apparent that cases of HUS typically are preceded by an episode of (often bloody) diarrhea (7) (8) (9) (10) , suggesting that an infectious agent was responsible. In the 1980s, this proved to be correct when a novel category of diarrheagenic Escherichia coli, so-called enterohemorrhagic E. coli (EHEC) , that was causally associated with the syndrome of hemorrhagic colitis (1, 4) and subsequently with HUS was discovered (1, 12, 16-18, 25, 26, 33) . While the prototype EHEC strain is of serotype 0157:H7, a number of other serotypes, such as 026:H11, O111:H8, and 0145:NM, are also recognized (20) .
The virulence properties manifested by EHEC include the elaboration of Shiga-like toxin I (SLT-I) or SLT-II (or both) encoded by bacteriophages (32, 34) , carriage of a plasmid associated with the expression of a novel variety of fimbriae that favors the attachment of EHEC to epithelial cells (14) , and the expression of a protein (encoded by a chromosomal gene) that results in intimate attachment to intestinal cells (36, 37) . The terms Verotoxin I and II (32) are synonymous with SLT-I and -II, respectively. The DNA sequence of SLT-I is identical to Shiga toxin elaborated by Shigella * Corresponding author. dysenteriae 1, while there is 58% sequence homology between antigenically distinct SLT-I and SLT-II (13) .
Several diagnostic tools have been developed on the basis of the virulence properties of EHEC, particularly 0157:H7. These include a DNA probe to detect the 60-MDa plasmid of EHEC (21) , as well as probes to detect the genes that encode SLT-I and -II and the phages that carry the SLT structural genes (27) . The use of serologic tests to measure significant rises in the serum titer of antitoxin or of 0157 antibody or of immunoassays to detect SLTs directly in stools increases the sensitivity of detecting EHEC infection since these assays are positive in a proportion of patients with negative cultures (17, 19, 23) . Although HUS is a well-studied clinical entity and an important public health problem in Argentina and Chile (4, 5, 9, 10, 22) , etiologic studies have been few and limited (21, 23, 31 20 lactose-positive coliform colonies from each plate were selected and confirmed as E. coli by using standard biochemical methods (6) .
Detection of EHEC by DNA probes. Confirmed E. coli colonies from the coproculture of each subject were transferred to Whatman filter papers for colony blot hybridization with biotinylated probes that detect the EHEC plasmid associated with fimbrial expression (21), SLT-I, and SLT-II (27) . The methods to prepare the filters and to prepare and use the biotinylated probes have been previously described in detail (11) . Briefly, the filters were treated with NaOH and heat to release DNA from the bacterial colonies, render it single stranded, and fix it to the solid phase. The filters were then exposed to a solution containing 1.5 mg of lysozyme per 100 ml and 25 g of sucrose per 100 ml for 30 min, washed, and then treated with a proteinase K solution (250 ,ug/ml) for 30 min at 37°C. The pCVD 419 EHEC probe is a 3.4-kb fragment of the EHEC plasmid of prototype strain 933 that serves as a highly sensitive and specific probe to detect EHEC. The SLT-I probe consists of a 1.1-kb phage-derived fragment that encodes 98% of the A subunit and the entire B subunit (27) . The SLT-II probe consists of an 0.84-kb fragment that encodes 95% of the A subunit (27) . For the purposes of this study, EHEC strains were defined as strains that hybridized with at least one of the probes. E. coli isolates were serogrouped by agglutination with 0 antisera obtained from ProBac, Sao Paulo, Brazil.
RESULTS
Characteristics of the patients and equivalence of the study groups. A comparison of the relevant demographic and clinical aspects of the two study groups is summarized in Table 1 . A total of 38 controls were matched to the 20 HUS patients (for two cases, only a single control was obtained, whereas for one case, the only available controls were more than 3 months apart in age). Thirteen of the 20 cases of HUS occurred during the summer months of December to March. All 20 HUS patients presented a prodrome of diarrheal disease, 13 of which experienced bloody diarrhea; the mean duration of the diarrheal illness (by history) was 4.6 days. Twelve HUS patients had a history of having received antibiotics during the prodromal diarrheal illness; four patients received amoxicillin or ampicillin, three got trimethoprim-sulfamethoxazole, three received furazolidone, one got neomycin (in a kaolin suspension), and one received chloramphenicol. At the time of admission to the hospital, 13 HUS patients were still suffering from diarrhea, while in the other HUS patients, diarrhea had ceased 1 to 7 days earlier.
Sixteen of the HUS patients presented to hospital with oliguria or anuria, and 10 were obtunded.
The hematological examinations in all patients revealed schistocytes and other abnormal morphologic forms of erythrocytes; hematocrits ranged from 14 to 29%, while hemoglobin counts were between 3.4 and 9.3 g%. Platelet counts were significantly diminished in 14 children, with a mean value of 41,571 per mm3. Blood urea nitrogen and creatinine levels were elevated, reaching means of 86 and 4.2 mg/100 ml, respectively.
Isolation of EHEC. Colony blot hybridization with the DNA probes detected EHEC in 6 of 20 HUS patients (30%) versus 2 of the 38 matched control children (5.3%) (P < 0.0158). Three of the eight HUS patients who did not receive antibiotics yielded EHEC (38%). There was a suggestion that the detection of EHEC may be related to the interval between the onset of the prodromal diarrheal illness and the time of obtaining stool cultures. For example, EHEC strains were detected in 3 of 4 children (75%) who had diarrhea for 1 to 4 days before culture, from 3 of 14 children (21%) who had diarrhea for 5 to 8 days before culture, and from 0 of 3 children who had onset of their diarrhea 9 to 11 days before stool cultures were taken. Virulence properties ofthe EHEC strains. The genotypes of the strains isolated from the study participants, including the six HUS patients and the two controls, are summarized in Table 1 . Five additional cases of HUS were detected in Santiago in October 1989 after completion of the casecontrol study. These patients were also cultured, and EHEC strains were isolated from two of these patients. These two EHEC strains were characterized along with strains from the case-control study. As shown in Table 1 , all strains hybridized with at least one of the toxin probes and with the EHEC plasmid probe ( Table 2 ). The most common pattern (seen in strains from five of eight HUS patients) revealed positivity with all three probes. EHEC strains from the patients with HUS included serogroups 0157 (three patients), 026 (three patients), and 0111 (two patients). EHEC strains from the two control patients were both of serogroup 026 (Table 2) .
Antibiotic sensitivity of the EHEC strains. The EHEC isolates from all HUS patients and from the controls were examined for susceptibility to antibiotics by the disk method. In total, 65% of the strains were resistant to ampicillin, 41% were resistant to trimethoprim-sulfamethoxazole, 29% were resistant to tetracycline, and 6% were resistant to chloramphenicol.
DISCUSSION
Observations made in this study in Chile show striking similarities to reports of HUS in North America and Europe and to the few reports from Argentina. As was the case in North America, HUS cases were more common in the summer. In Chile, 30% of the HUS patients yielded EHEC strains in their stooI cultures, a significant difference from the 5.3% recovery rate in healthy control children (P = 0.0158). Worldwide, there have been only a few prospective studies in which stool cultures from patients with HUS were systematically tested for E. coli that produce SLTs and even fewer in which matched control children were sampled. These studies differ from one another in the methodologies used to identify EHEC (in this context defined as any SLT-producing strain). Nevertheless, the rate of isolation of EHEC from Chilean children with HUS is similar to the rates of isolation from HUS patients in North America (17, 25) , the United Kingdom (19) , and Germany (2) ( Table 3) . As in other studies, the isolation of EHEC from controls was low.
A characteristic feature of EHEC infection in patients with hemorrhagic colitis and HUJS is the short duration of fecal shedding of the organisms, which leads to an underestimation of the magnitude of the EHEC problem (35) . The use of serologic tests to measure significant rises in serum titer of antitoxin or of 0157 antibody or of immunoassays that detect SLTs in stools increases the sensitivity of detecting EHEC infection since these assays are positive in a proportion of patients with negative cultures (17, 19, 23) . It is likely that if these additional methods had been employed in this study, the proportion of HUS cases judged to be due to EHEC would be even higher.
A slightly higher rate of recovery (3 of 8 [38%]) of EHEC was found in the Chilean HUS patients who had not received antibiotics during the prodromal illness. On the other hand, some clinicoepidemiological studies suggest that prior antibiotic therapy may be a risk factor for development of HUS (3, 24, 28) . A possible explanation for this may lie in results of microbiological studies that show that the expression and release of SLTs are increased when EHEC bacteria are exposed to sublethal concentrations of certain antimicrobial agents such as trimethoprim-sulfamethoxazole (15) .
As is the case in North America, Europe, and neighboring Argentina, circa 90% of Chilean HUS patients experience a prodrome of diarrhea (4, 5) , which is bloody in approximately one-half of the patients. HUS is well recognized to occur as a complication in a few percent of patients during outbreaks of diarrheal illness and hemorrhagic colitis due to EHEC (28, 33) . Thus, it is now appreciated that the spectrum of EHEC infection includes asymptomatic carriage, nonbloody diarrhea, hemorrhagic colitis, and, at the severe end, HUS.
The eight HUS patients in our study were infected with EHEC serogroups (0157, 026, and 0111) that are well recognized in North America and Europe (1, 2, 3, 17, 19, 29, 30) ; H typing was not carried out. Notably, all strains possessed the EHEC plasmid and at least one SLT; strains from five of the eight HUS patients possessed genes for both SLT-I and SLT-II, while three had only SLT-I. In North America and Europe, EHEC strains from HUS patients most commonly express SLT-II with or without SLT-I (1-3, 19, 27, 32, 34) .
Positive features of this clinicoepidemiological study of EHEC were the practicality and ease of use of the three biotinylated gene probes. These advantages suggest that the probes might be quite useful in performing studies that investigate the human, animal, and environmental reservoirs of EHEC, modes of transmission, and risk factors for development of diarrhea, hemorrhagic colitis, and HUS.
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